91
References
Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res. 1999, 39, 41–47.
Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991, 57, 1–7.
Barnes PJ, Adcock IM. NF-kappa B: a pivotal role in asthma and a new target for therapy.
Trends Pharmacol Sci. 1997, 18, 46-50.
Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest. 1985, 76, 2003-2011.
Bevilacqua MP, Nelson RM. Selectins. J Clin Invest. 1993, 91, 379-387.
Bharat BA, Anushree K, Manoj SA, Shishir S. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. Phytopharmaceuticals in Cancer Chemoprevention. 2005, 20, 349-387.
Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis.
Atherosclerosis. 2003, 170, 191-203.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72, 248–254.
Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem
92
Pharmacol. 1995, 49, 1551–1556.
Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT.
Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci. 1998, 95, 11715-11720.
Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-kappa B, a ubiquitous transcription factor in the initiation of diseases. Clin Chem.
1999, 45, 7-17.
Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21, 2895-2900.
Christopher R, Nalini A. Cerebral lipidoses in patients with progressive neurodegenera- tion: a study from south India. Community Genet. 2002, 5, 186-191.
Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med. 1998, 25, 891-897.
Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res. 1980, 71, 632-634.
Dhawan S, Weeks B, Soderland C, Schnaper H, Toro L, Asthana S, Hewlett I, Stetler-Stevenson W, Yamada S, Yamada K, Meltzer M. HIV infection alters monocyte interactions with human microvascular endothelial cells. J Immunol 1995, 154, 422–432.
DiCorleto PE, de la Motte CA. Characterization of the Adhesion of the Human Monocytic Cell Line U937 to Cultured Endothelial Cells. J Clin Invest. 1985, 75, 1153-1161.
93
Dschietzig T, Richter C, Pfannenschmidt G, Bartsch C, Laule M, Baumann G, Stangl K.
Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: possible involvement of a nuclear factor kappa B dependent mechanism.
Intensive Care Med., 2001, 27, 751-756.
Duranteau J, Chandel NS, Kulisz A, Shao Z, Schumacker PT. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem. 1998, 273, 11619-11624.
Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986, 137, 245-254.
Fang J, Lu J, Holmgren A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem. 2005, 280, 25284-25290.
Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu.Rev.Immunol. 1998, 16, 225-260.
Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2003, 108, 1912-1916.
Gupta B, Ghosh B. Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol. 1999, 21, 745-757.
Han SS, Keum YS, Seo HJ, Surh YJ. Curcumin suppresses activation of NF-kappa B and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol. 2002, 35, 337-342.
94
Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003, 91, 7A–11A.
Hatada EN, Do RK, Orlofsky A. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J Immunol. 2003, 171, 761–768.
Hillis GS, Flapan AD. Cell adhesion molecules in cardiovascular disease: a clinical perspective. Heart. 1998, 79, 429–431.
Huang MT, Ma W, Lu YP, Chang RL, Fisher C, Manchand PS, Newmark HL, Conney AH. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydro- curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion.
Carcinogenesis. 1995, 16, 2493-2497.
Hynes RO. Integrins: a family of cell surface receptors. Cell. 1987, 48, 549–554.
Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992, 69, 11–25.
Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973, 52, 2745-2746.
Jaiswal AS, Marlow BP, Gupta N, Narayan S. Beta-catenin-mediated transactivation and cell–cell adhesion pathways are important in curcumin (diferuloylmethane)-induced growth arrest and apopstosis in colon cancer cells. Oncogene. 2002, 21, 8414–8427.
Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 1994, 24, 1591–601.
Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB.
95
Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999, 163, 3474–3483.
Kumar A, Dhawan S, Hardegen NJ, Aggarwal BB. Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem Pharmacol. 1998, 55, 775-783.
Li C, Browder W, Kao LR. Early activation of transcription factor NF- B during ischemia in perfused rat heart. Am J Physiol. 1999, 276, H543–552.
Li HB, Cheng KW, Wong CC, Fan KW, Chen F. Evaluation of antioxidant capacity and total phenolic content of different fractions of selected microalgae. Food Chemistry. 2007, 103, 771–776.
Li N, Karin M. Is NF-κB the sensor of oxidative stress? FASEB J. 1999, 13, 1137–1143.
Li Y, Zhang W, Mantell LL, Kazzaz JA, Fein AM, Horowitz S. Nuclear factor-κB is activated by hyperoxia but does not protect from cell death. J Biol Chem. 1997, 272, 20646-20649.
Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activated protein-1. J Biol Chem. 1998, 273, 13245–13254.
Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993, 92, 1866 –1874.
96
Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol. 1995, 49, 1165-1170.
McEver RP, Moore KL, Cummings RD. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem. 1995, 270, 11025–11028.
Medford RM. Antioxidants and endothelial expression of VCAM-1: a molecular paradigm for atherosclerosis. In: Gallo LL, ed. Cardiovascular Disease. 1995, 2, 121–127.
Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Miller AA. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci. 1993, 84, 407–12.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983, 65, 55–63.
Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993, 178, 449–460.
Muller JM, Rupec RA, Baeuerle PA. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods. 1997, 11, 301–312.
Offermann MK, Medford RM. Antioxidants and atherosclerosis: a molecular perspective.
Heart Dis Stroke. 1994, 3, 52–57.
Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L.
Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex, Oncogene, 1999 , 44, 6013–6020.
97
Pober JS, Gimbrone MA, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA.
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J.Immunol. 1986, 137, 1893-1896.
Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med. 1999, 107, 85-97.
Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol. 2006, 72, 1439-1452.
Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995, 57, 791-804.
Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999, 138, 419-20.
Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 1995, 94, 79-83.
Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J.Biol.Chem., 1995, 270, 24995-25000.
Schleimer RP, Rutledge BK. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J.Immunol., 1986, 136, 649-654.
Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic.Res.Commun., 1992, 17, 221-237.
Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med. 1992, 175, 1181–1194.
98
Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J.
1991, 10, 2247–2225.
Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986, 46, 705-16.
Shishodia S, Potdar P, Gairola CG, Aggarwal BB. Curcumin (diferuloylmethane) downregulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis. 2003, 24, 1269–1279.
Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J. Physiol. 1998, 275, C1640-C1652.
Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer.
Cancer Res. 2002, 62, 3868-3875.
Springer, TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994, 76, 301–314.
Springer TA, Adhesion receptors of the immune system. Nature. 1990, 346: 425–434.
Suzuki YJ, Packer L. Inhibition of NF-κB activation by vitamin E derivatives. Biochem Biophys Res Commun. 1993, 193, 227–283.
Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest. 2001, 107, 7–11.
Thornburg NJ, Pathmanathan R, Raab-Traub N. Activation of nuclear factor -kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res. 2003, 63,
99
8293–8301.
Thurberg BL, Collins T. The nuclear factor kappa-B/inhibitor of kappa-B autoregulatory system and antherosclerosis. Curr Opin Lipidol. 1998, 9, 387–396.
True AL, Rahman A, Malik AB. Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2000, 279, 302–311.
Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, Kwiatkowski D.
Functional consequences of a polymorphism affecting NF-kappa B p50-p50 binding to the TNF promoter region. Mol Cell Biol. 2000, 20, 9113–9119.
Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol.
2001, 38, 307–314.
Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5’-regulatory region. Induction by cytokines and phorbol ester. J Immunol. 1991, 147, 2777–2786.
Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol. 1978, 43, 86–92.
Wallin B, Rosengren B, Shertzer HG, Camejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal Biochem. 1993, 208, 10–5.
Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med. 1999, 27, 612–616.
Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK. Stability of curcumin in buffer solution and characterization of its degradation products. J Pharm Biomed Anal.
100
1997, 15, 1867–1876.
Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science. 1990, 247, 456–459.
Jiao Y, Wilkinson J, Christine Pietsch E, Buss JL, Wang W, Planalp R, Torti FM, Torti SV. Iron chelation in the biological activity of curcumin Free Radical Biology &
Medicine. 2006, 40, 1152 – 1160.
Yamaguchi T, Takamura H, Matoba T, Terao J. HPLC method for evaluation of the free radical-scavenging activity of foods by using 1,1-dipheny-2-picrylhydrazyl, Biosci.
Biotechnol. Biochem. 1998, 62, 1201–1204.
Zibara K, Chignier E, Covacho C, Poston R, Canard G, Hardy P, McGregor J.
Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule- 1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice.
Arterioscler. Thromb Vasc Biol. 2000, 20, 2288–2296.
101
Appendix 1
Table 1. Antioxidative capacities of carnosic acid in vitro.
Inhibition of LDL DPPH radicals TEAC Oxidation scavenging ability
(IC50, μmol/l) (IC50, μmol/l)
carnosic acid 5.63±0.19 35.9±1.7 5.75±0.49
All values are mean ± S.D. IC50 values were obtained from the concentration response curves; n =3.